Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret
Fierce Pharma
MARCH 10, 2023
Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret kdunleavy Fri, 03/10/2023 - 10:22
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Fierce Pharma
MARCH 10, 2023
Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret kdunleavy Fri, 03/10/2023 - 10:22
Fierce Pharma
OCTOBER 2, 2023
Even as Biogen weighs strategic options for its biosimilars unit, the group is celebrating an industry first. | The exact launch timing of the biosimilar remains unclear, but Roche said it expects competition to kick off in the second half of 2023.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 11, 2023
With Xspray Pharma and Eversana’s cancer med hitting a regulatory setback, a launch in the second half of 2023 now looks unlikely. With Xspray Pharma and Eversana’s cancer med hitting a regulatory setback, a launch in the second half of 2023 now looks unlikely.
European Pharmaceutical Review
NOVEMBER 3, 2022
Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Competitiveness. Key countries. Finished Dosage. Growth potential.
European Pharmaceutical Review
APRIL 28, 2023
The European Commission ’s (EC’s) reform of the EU pharmaceutical legislation published on 26 April 2023, adopted a proposal for a new Directive and a new Regulation. To mitigate this, he strongly recommended “a comprehensive competitiveness check is conducted on the impact of the revised pharmaceutical legislation.”
PM360
SEPTEMBER 21, 2023
Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.
Star OUTiCO
NOVEMBER 30, 2022
January is one of the busiest recruiting times, so starting your hunt this month could mean lower competition and possibly improve your odds of securing your dream job. Reassess ahead of 2023. Some larger pharma clients are really going above and beyond to try and dangle that golden carrot Sarah Whitby, Pharma Outsourcing Lead.
European Pharmaceutical Review
MARCH 7, 2023
The Pistoia Alliance has launched its Pharma Innovation Council. The Council will explore common challenges develop ideas for new pre-competitive projects aligned with the Alliance’s strategic themes, including Emerging Sciences and Technology and Improving the Efficiency and Effectiveness of R&D.
European Pharmaceutical Review
SEPTEMBER 13, 2023
As small and medium-sized enterprises (SMEs) often face unfair competition when doing business in Europe, through the (SME) Relief Communication, the European Commission (EC) has proposed new measures to provide short-term relief, boost long-term competitiveness, and improve equality in the business environment across the Single Market in Europe.
pharmaphorum
DECEMBER 28, 2022
M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.
Pharma Marketing Network
APRIL 5, 2023
Attending the Reuters Pharma Marketing 2023 event on March 28-29 was a fascinating experience as the pharma marketing industry continues to return to in-person events. We also saw the addition of a track focused on Cell and Gene Therapy, as Pharma ventures into the commercialization of therapeutics.
Impetus Digital
AUGUST 2, 2024
Looking back at 2023 , AI for drug discovery saw both wins and losses. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.
PM360
APRIL 7, 2023
However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. pharma sales in 2020) and the size of 340B discounts (25-50%), companies may see significantly reduced revenues for important products.
pharmaphorum
DECEMBER 15, 2022
A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. “The industry now regards the current approach, due to end in 2023, as broken.” VPAS tax on top. . VPAS tax on top. .”
Pharmaceutical Technology
DECEMBER 4, 2022
Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Indeed, Amgen’s biosimilar was approved in September 2016, but the company was not able to launch it until January 2023 in the US. Temporary first-to-market advantage.
pharmaphorum
SEPTEMBER 15, 2022
The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”
Pharmaceutical Technology
MAY 11, 2023
The global pharma industry experienced a 9% drop in social media posts on internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for U.S. Of the 50 leading companies in the pharma industry, U.S. Buy the report here.
European Pharmaceutical Review
NOVEMBER 30, 2023
Cell and gene therapy industry in 2023 According to data from the GMP Manufacturing Survey, in the past year: “There is an increase in the number of manufacturing organisations and the number of licensed facilities has remained stable. The 2023 data found that the split for bioprocessing roles was 57 percent.
pharmaphorum
SEPTEMBER 5, 2022
The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director. ” The action will only be heard if the Competition Appeal Tribunal (CAT) upholds the CMA’s findings against Alliance, it added. .”
pharmaphorum
JULY 21, 2022
The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward. billion ($33.2
Pharma Marketing Network
MARCH 23, 2023
As cookies become obsolete, pharma marketers will need to find new ways to reach and engage with consumers. For example, pharma marketers can use email marketing to reach consumers with relevant health and wellness information, or use SMS marketing to send appointment reminders or refill notifications. References: 1. ” Hubspot.
Clarivate
DECEMBER 19, 2022
For 2023 Medicare Advantage open enrollment, the United States’ largest retailer will begin a 10-year partnership with the nation’s largest insurer. The partnership dovetails with Walmart Health’s plans for 15 new Florida clinics across the Jacksonville, Orlando and Tampa markets by the end of 2023. MA national enrollment.
PharmaKinnex
SEPTEMBER 28, 2022
How PharmaKinnex Helps You Plan For A Better 2023 September 27, 2022. Everyone knows that over the next few weeks and months, businesses in the pharma marketing industry will meet to discuss next year’s budget. Keep reading to find out more about how our pharma marketing services can help make 2023 your best year yet.
European Pharmaceutical Review
MAY 13, 2024
Notably, 47 percent of respondents from the pharma and healthcare sectors considered that financial performance was “the main task of procurement”. Sustainability of the future pharma supply chain “Companies are now receiving uniform rules for the entire EU, which is particularly advantageous for the healthcare industry.
Eversana Intouch
JANUARY 19, 2023
Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. – is changing, and has big implications for the competitive marketplace. Pharma marketers in 2023 need to: Look for blind spots. or technology, too?
PM360
OCTOBER 13, 2023
For the next 12 to 24 months, the media landscape is set to drastically change and pharma marketers can’t miss this hidden opportunity. billion in 2023 from these fees. Threads on the other hand is the spitting image of brand safety—if pharma developed an industry-centric platform, this would be it. Will streaming evolve?
Pharmaceutical Technology
DECEMBER 19, 2022
in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Furthermore, for months, several financial institutions such as Bank of America and JP Morgan have been talking of a “mild recession” in 2023 for the US. by the end of 2023 and may continue to rise in 2024 to 5%.
Pharmaceutical Representative Training
JANUARY 29, 2025
The Limitations of Traditional Pharma Sales Methods Pharmaceutical sales in the past depended largely on face-to-face interactions; now, these salespeople spend more time working remotely. Impact of CRM Tools on Pharma Sales CRM tool adoption has dramatically improved sales effectiveness and HCP engagement.
Healthcare Success
NOVEMBER 7, 2022
They’re researching key trends that will attract new high-intent audiences, increase engagement, drive revenue, and reinforce patient loyalty in 2023. In this article, you’ll learn: 4 Advertising Planning Strategies for 2023 6 Marketing Strategies That Outpace Market Disruption. 4 Advertising Planning Strategies for 2023.
PM360
DECEMBER 20, 2023
With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. This allows for a complementary portfolio fit without the kind of competitive overlap that comes under regulatory scrutiny from the FTC.
pharmaphorum
SEPTEMBER 7, 2022
Gilead Sciences’ Kite Pharma unit has carved out a niche for its CD19-targeted CAR-T therapy Tecartus in acute lymphoblastic leukaemia (ALL) in Europe, free of direct competition from arch-rival Novartis. However, results from that are not due until 2023.
eMediWrite
AUGUST 30, 2023
Pharma MSMEs might not have the negotiation leverage or other options necessary to properly handle late payments. Challenges posed by payments that are late for pharma MSMEs For pharma MSMEs, late payments present formidable obstacles. The solution to the issue of delayed payments is collaboration.
Pharmaceutical Technology
DECEMBER 15, 2022
It also stresses that some pharma manufacturers are at risk of having gas rationed or being unable to continue manufacturing due to high prices. Once a drug’s patent expires, numerous pharma companies offer generic versions, which can then reduce drug pricing by as much as 80-90%, leading to small profit margins for generics makers.
Pharmaceutical Representative Training
JANUARY 8, 2025
1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? ACMA offers two accredited certification programs that prepare representatives with knowledge of the pharma industry, the drug development process, healthcare economics and, most importantly, pharmacology. Pharma Sales.
Clarivate
JANUARY 23, 2024
The just-published 2023 Factbook indicates an industry that is becoming more nimble and efficient in its R&D over the long haul. Figure 1: Number of NME launches from 2013 to 2022 Analyses from the 2023 R&D Factbook also indicate that the number of late phase terminations has consistently declined in recent years.
pharmaphorum
AUGUST 2, 2022
Now, Roche has an opportunity to add ease of administration to the competitive profile of Tecentriq, reducing the time patients have to spend in clinics and potentially reducing the cost of treatment. Results from a trial in first-line NSCLC are due in early 2023.
Pharmaceutical Technology
JUNE 6, 2023
Chicago, Illinois-based Ellipses Pharma has announced its intention to accelerate the global clinical development of its selective RET inhibitor EP0031/A400. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.
Star OUTiCO
DECEMBER 1, 2023
This time of year is particularly competitive for recruitment within pharma, medtech, and biotech, so setting goals and staying organised will help you immeasurably. ‘ This time of year is particularly competitive for recruitment within pharma, medtech, and biotech, so setting goals and staying organised will help you immeasurably. ‘
pharmaphorum
AUGUST 26, 2022
BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe. If approved will price the gene therapy at $2 to $3 million after discounts, saying the price there will reflect the higher price of current treatments.
PM360
SEPTEMBER 30, 2024
This article outlines how developers can utilize sustainability initiatives to boost revenue, reduce costs, and advance innovation, ensuring a strategic, long-term, and more sustainable position in today’s competitive landscape. Continued innovation is crucial in enhancing sustainability within pharma and the broader biotech industry.
European Pharmaceutical Review
NOVEMBER 8, 2022
Under two other pending bills – House of Representatives Bill 2883, titled Stop Stalling Access to Affordable Medications, and Senate Bill 1425, titled Stop STALLING 4 Act – it would be unfair competition to submit an “objectively baseless petition” to the FDA in an attempt to interfere with a competitor’s application to market a drug.
Clarivate
APRIL 24, 2023
After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.
Clarivate
JULY 5, 2023
The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. When AMJETIVA finally launched at the end of January 2023, its unusual, tiered pricing strategy made headlines. Clarivate research indicates biosimilar competition will drive down prices and relative market share of HUMIRA ® in the U.S.
Pharmaceutical Technology
DECEMBER 20, 2022
trillion in Q3, according to GlobalData’s Pharma Intelligence Center Companies Database. The growing competition from generic drugs presents challenges for the top 20 players placing pressure on drug prices. The top 20 global biopharmaceutical companies exhibited a downward trend in aggregate market capitalisation by 9.1%
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content